ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery and diagnostics. The platform was established by five different universities together with a range of Danish and interantional companies within pharma and biotech.
COMPANIES should join ODIN to:
ACADEMICS should join ODIN to:
Browse the website to find more information, or contact us to learn more.
ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery and diagnostics. The platform was established by five different universities together with a range of Danish and interantional companies within pharma and biotech.
COMPANIES should join ODIN to:
ACADEMICS should join ODIN to:
Browse the website to find more information, or contact us to learn more.
We unite right minds from industry and academia so that they can jointly create need-driven research projects - and pave the way for innovative new treatments in the future. Through competitive funding calls, we fund the best projects ideas. Although companies cannot receive funding, it is free of charge to join.
The 5-year platform is sponsored by the Novo Nordisk Foundation with 180 M DKK from 2024-2028.
You are always welcome to reach out if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although we're spanning five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 121, blg 1521-216.
